EVERSANA

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

Oncology

Tim Lewis, Vanitha Sankaran, Sarah Henry, Jordan Schell - with pharmaphorum

ASCO 2025 insights: EVERSANA experts on AI, biomarkers, and ...

Sales & Marketing

Just call it ‘good marketing’: Dan Gandor on why omnichannel...

A Q&A with EVERSANA's new Head of Omnichannel and Digital Transformation covers omnichannel, AI, pharma marketing headwinds, and more.

News

EVERSANA adds AI to medical, legal and regulatory reviews

A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.

Patients

How pharma is tackling new direct-to-patient programmes

At Reuters Pharma USA, executives from AstraZeneca, Gilead, Kyowa Kirin, and EVERSANA discussed the what, why, and how of direct-to-patient models.

Patients

Reuters pharma USA 2025 Faruk Abdullah interview

Direct-to-patient is more than just telehealth – with EVERSA...

Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.